Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

3.80
Delayed Data
As of 3:59pm ET
 +0.05 / +1.33%
Today’s Change
2.63
Today|||52-Week Range
6.30
+4.97%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close3.75
Today’s open3.75
Day’s range3.74 - 4.09
Volume53,522
Average volume (3 months)72,855
Market cap$80.5M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)+19.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-17.15%
P/E ratioNM
Price/Sales22.39
Price/Book35.41

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd+0.02+2.84%
SPHSSophiris Bio Inc-0.01-0.38%
IMMYImprimis Pharmaceuti...+0.03+0.73%
NVETNexvet Biopharma plc-0.01-0.15%
Data as of 3:59pm ET, 04/25/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.83
Annual revenue (last year)$2.5M
Annual profit (last year)-$38.0M
Net profit margin-1,499.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs